Insulet reports positive trial data for next-generation diabetes systems
Go back to Insulet reports positive trial data for next-generation diabetes systems| Insulet Corporation (NASDAQ: PODD) | Delayed: 138.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.97 | 52 Week High | $45.60 | |||
| Open | $138.97 | 52 Week Low | $23.94 | |||
| Day High | $138.97 | P/E | N/A | |||
| Day Low | $138.97 | EPS | $-1.00 | |||
| Volume | 932 | |||||
